Skip to main content
. 2013 Apr 5;288(21):15046–15056. doi: 10.1074/jbc.M113.466136

FIGURE 8.

FIGURE 8.

Involvement of MEK and ERK in hnRNP-K-induced cell migration. Cells treated with MEK1/MEK2 inhibitor, U0126, showed decrease in ERK (p44/42). Increase in MMP-3 in hnRNP-K-overexpressing cells was compromised by treatment with the inhibitor (A). ERK1/ERK2 inhibitor FR180204 resulted in decreased level of hnRNP-K confirming cross-talk between MEK, ERK, and hnRNP-K as proposed in the model (Fig. 7). Treatment of hnRNP-K-overexpressing cells with MMP-3 inhibitor resulted in their decreased invasion capacity.